News und Analysen

AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its fourth quarter and full year

Regulatory News:

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR

Vifor Pharma Group reported a solid performance in 2021 and an increase in profitability, supported by a strong recovery in Ferinject

Regulatory News:

AD HOC-MITTEILUNG GEMÄSS ART. 53 KR

Die Vifor Pharma Gruppe verzeichnete 2021 eine solide Geschäftsentwicklung und eine Steigerung der Profitabilität, die von einer starken

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of patients with cancer and autoimmune diseases

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its fourth quarter and year-end 2021 results on Monday, February 28, 2022, after the close of the market. Acadia

AMN Healthcare (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the nation, today announced it was named among America’s Best Employers for 2022

Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the fourth-quarter and full-year 2021 and reaffirmed guidance for 2022. For the quarter, revenue was $905.1

Vifor Pharma Deutschland GmbH hat heute die Markteinführung von Tavneos^® bekannt gegeben, der ersten in Europa zugelassenen oralen Therapie für die Behandlung der beiden Haupttypen von

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute die Ergebnisse für das vierte Quartal und das Gesamtjahr 2021 bekannt.

Der Konzernumsatz stieg im vierten Quartal 2021 gegenüber

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced results for the fourth quarter and full-year 2021.

Net sales for Q4 2021 rose 2% (+4% CER) to $582 million from Q4 2020, well

Premier Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, announced today that members of its management team are scheduled to participate in a virtual fireside chat

Premier Inc. (NASDAQ: PINC), a leading healthcare improvement and technology company, has been awarded the 2022 Best in KLAS designation for Value-Based Care Consulting. The award was announced in

Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2021, on Thursday, February 24, 2022, following the close of trading

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its QuantiFERON tuberculosis (TB) testing solution has gained additional momentum with the approval of the fourth

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute bekannt, dass seine Tuberkulose (TB)-Testlösung QuantiFERON weiter an Dynamik gewonnen hat, nachdem die vierte Generation des

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced

For the third year in a row, AMN Healthcare (NYSE: AMN) has been named one of the country’s most responsible companies by Newsweek and Statista Action for its commitment and action to promote

Regulatory News:

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR

Vifor Pharma Group today announced the appointment of acting Chief Financial Officer Alexandros Sigalas and Group General Counsel Dr

Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal year 2022 second quarter ended December 31, 2021.

"Our

AMN Healthcare’s commitment to diversity, equity, equality, and inclusion has again been recognized in the business world with the company’s listing in two top corporate indexes that measure